feed
view company updates
tools
perform investment research
network
join events & discussions
advisory
about us
INVEST IN FUNDS
Lytix Biopharma: Interview with CEO Øystein Rekdal
Research Interview
2024-05-31
16:00
Redeye interviews CEO Øystein Rekdal about the Q1 2024 report.
RR
Richard Ramanius
Sign up for free to continue
Sign up with Email
Sign in with Google
Already a member?
Sign in
Disclosures and disclaimers
Premium Plan required to unlock
Unlock companies to access
more high quality research.
View Plans